SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-027232
Filing Date
2024-08-19
Accepted
2024-08-19 17:06:15
Documents
64
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q wint20240630_10q.htm   iXBRL 10-Q 1354534
2 EXHIBIT 31.1 ex_680957.htm EX-31.1 15868
3 EXHIBIT 32.1 ex_680958.htm EX-32.1 7386
  Complete submission text file 0001437749-24-027232.txt   6513525

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA wint-20240630.xsd EX-101.SCH 61023
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wint-20240630_cal.xml EX-101.CAL 34388
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20240630_def.xml EX-101.DEF 506608
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20240630_lab.xml EX-101.LAB 358602
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20240630_pre.xml EX-101.PRE 517567
67 EXTRACTED XBRL INSTANCE DOCUMENT wint20240630_10q_htm.xml XML 781476
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39290 | Film No.: 241221490
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)